Enzon Pharmaceuticals
Mr. Richard L. Feinstein (CEO, CFO & Company Sec.)
Summary
History
Enzon Pharmaceuticals, Inc started its earliest business in 1981. Now, the focus of the company is mainly on development and production of drugs for cancer patients with high unmet needs. It is also actively researching on improving the chemical attachment of PEG to help provide antibodies in molecules.
In 2010, Enzon Pharmaceuticals, Inc.sold its specialty pharmaceutical business to the sigma-tau Group .
Mission
Vision
Key Team
Mr. Richard L. Feinstein (CEO, CFO & Company Sec.)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Mr. Richard L. Feinstein (CEO, CFO & Company Sec.)
